The pharmacoepidemiological research group at University of Southern Denmark is an internationally recognized research group with more than 30 years of experience in register-based research. The research group uses primarily the Danish health registries to examine utilization patterns as well as desired effects and adverse drug reactions when using prescription drugs.
We develop methods, infrastructure, and practice within pharmacoepidemiology. This involves improving existing analysis methods or developing new ones, as well as holding courses, sharing codes, and publishing tutorials and supporting material for other researchers. In addition, the group is extremely active in both the Danish Society for Pharmacoepidemiology, in the Nordic network for Pharmacoepidemiology, and in the International Society for Pharmacoepidemiology.
In addition to method development, the group is widely recognized for applied pharmacoepidemiological research within virtually all therapeutic areas, i.e. studies of specific drug effects, with the aim of creating knowledge that can be used by clinicians, patients, and regulators.
Our research domains are:
- Drug utilization research
- Pediatric pharmacoepidemiology
- Translational research
- Deprescribing
- Cancer pharmacoepidemiology
- Methods development within pharmacoepidemiology
- Practices for hypothesis-free screening
Our partners:
Center for Pharmaceutical Data Science Education: based at the University of Copenhagen, the aim is to integrate data science into pharmaceutical education at the Bachelor’s, Master’s, PhD, and continuing education levels.
SIGMA consortium: A European network that facilitates regulatory work between pharmaceutical manufacturers and scientific partners with access to real-world data, with the objective of addressing regulatory scientific questions.
Odense University Hospital, Hospital Pharmacy: collaboration on research regarding deprescribing.